Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 36996387

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Jun 1
First author
van Weelderen RE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Pediatr. 2023 Oct 30;12(10):1920-1925. doi: 10.21037/tp-23-360.
    note
    Source null
    related pmid
    37969120
    relationship
    Comment in
  2. citation
    Transl Pediatr. 2023 Dec 26;12(12):2099-2102. doi: 10.21037/tp-23-436.
    note
    Source null
    related pmid
    38197101
    relationship
    Comment in

Authors and identifiers

  1. name
    van Weelderen RE
    type
    Author
  2. name
    Klein K
    type
    Author
  3. name
    Harrison CJ
    type
    Author
  4. name
    Jiang Y
    type
    Author
  5. name
    Abrahamsson J
    type
    Author
  6. name
    Arad-Cohen N
    type
    Author
  7. name
    Bart-Delabesse E
    type
    Author
  8. name
    Buldini B
    type
    Author
  9. name
    De Moerloose B
    type
    Author
  10. name
    Dworzak MN
    type
    Author
  11. name
    Elitzur S
    type
    Author
  12. name
    Fernández Navarro JM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    van Weelderen RE
    type
    Author
  2. name
    Klein K
    type
    Author
  3. name
    Harrison CJ
    type
    Author
  4. name
    Jiang Y
    type
    Author
  5. name
    Abrahamsson J
    type
    Author
  6. name
    Arad-Cohen N
    type
    Author
  7. name
    Bart-Delabesse E
    type
    Author
  8. name
    Buldini B
    type
    Author
  9. name
    De Moerloose B
    type
    Author
  10. name
    Dworzak MN
    type
    Author
  11. name
    Elitzur S
    type
    Author
  12. name
    Fernández Navarro JM
    type
    Author
bibliography ids
  1. nci-bib-58ae1db813855aa8012df704
book metadata
content sha256
6a87dcc6cfd42ba1a4a8913706a1ca80532b58a8cc89cfb294f6f57f5a5912c6
document type
citation
dois
  1. 10.1200/JCO.22.02120
electronic publication date
display
2023 Mar 30
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:36996387
immutable id
pubmed:36996387@6a87dcc6cfd42ba1a4a8913706a1ca80532b58a8cc89cfb294f6f57f5a5912c6
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
16
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2963-2974
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Transl Pediatr. 2023 Oct 30;12(10):1920-1925. doi: 10.21037/tp-23-360.
    note
    Source null
    related pmid
    37969120
    relationship
    Comment in
  2. citation
    Transl Pediatr. 2023 Dec 26;12(12):2099-2102. doi: 10.21037/tp-23-436.
    note
    Source null
    related pmid
    38197101
    relationship
    Comment in
outcomes validated
false
pmid
36996387
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
a18713d3d74f3175b3326e671d8024019082f53cf7cfc381c43eb48431c7a9d1
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Jun 1
precision
day
year
2023
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
  3. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36996387/
title
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.

Preserved source evidence · Independent clinical review pending · Not medical advice